Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus gliclazide in diabetes with heart failure
ISRCTN05434670Phase 4Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Oct 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) and heart failure (HF) comparing Metformin arm with Gliclazide arm (2 arms). Primary endpoint: Difference in left ventricular end-systolic volume. Started Oct 2006; status: terminated.
02
Drugs
metformingliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on ISRCTN05434670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN05434670.